文献
J-GLOBAL ID:201702241014349509
整理番号:17A1189382
進行結腸直腸癌に対する新規抗体治療としてMABp1:無作為化,二重盲検,プラセボ対照,第3相試験【Powered by NICT】
MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
著者 (17件):
Hickish Tamas
(Poole Hospital NHS Foundation Trust, Poole, Dorset, UK)
,
Hickish Tamas
(Oncology Department, Royal Bournemouth Hospital NHS Foundation Trust Bournemouth, UK)
,
Hickish Tamas
(Department of Oncology, Bournemouth University, Bournemouth, UK)
,
Andre Thierry
(Oncology Department, Saint Antoine Hospital, and Pierre and Marie Curie University (Paris 6), Paris, France)
,
Wyrwicz Lucjan
(Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland)
,
Saunders Mark
(Christie Hospital, Manchester, UK)
,
Sarosiek Tomasz
(Oncology Department, Magodent, Warsaw, Poland)
,
Kocsis Judit
(University of Debrecen, Debrecen, Hungary)
,
Nemecek Radim
(Masaryk Memorial Cancer Institute, Brno, Czech Republic)
,
Rogowski Wojciech
(Clinical Department of Chemotherapy, Hospital Ministry of the Interior and Administration and Warmia and Mazury Oncology Centre, Olsztyn, Poland)
,
Lesniewski-Kmak Krzysztof
(Gdynia Cancer Centre Hospital. Gdynia, Poland)
,
Petruzelka Lubos
(General University Hospital in Prague, Prague, Czech Republic)
,
Apte Ron N
(Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel)
,
Mohanty Prasant
(XBiotech USA, Austin, TX, USA)
,
Stecher Michael
(XBiotech USA, Austin, TX, USA)
,
Simard John
(XBiotech USA, Austin, TX, USA)
,
de Gramont Aimery
(Oncology Department, Institut Hospitalier Franco-Britannique, Levallois-Perret, France)
資料名:
Lancet Oncology
(Lancet Oncology)
巻:
18
号:
2
ページ:
192-201
発行年:
2017年
JST資料番号:
W1266A
ISSN:
1470-2045
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)